Advertisement
Tempus signs 'groundbreaking' deal with cancer doctors group

Tempus signs 'groundbreaking' deal with cancer doctors group

By John Pletz  |  December 21, 2017

Tempus, Eric Lefkofsky's startup that's tackling cancer treatment with big data, just got a major boost in the data department. The Chicago-based company and a partner are getting access to CancerLinQ, a database of treatment results developed by the American Society of Clinical Oncology.

Lefkofsky's Tempus raises $70 million

Lefkofsky's Tempus raises $70 million

By John Pletz  |  September 25, 2017

Tempus, Eric Lefkofsky's cancer-data company, is getting a $70 million boost from some familiar partners: New Enterprise Associates and Revolution Growth. The two Washington, D.C.-area venture funds led a new round of financing that brings the total outside investments in Tempus to $130 million.

Singleton to retire as CEO of Inova after 35 years

Singleton to retire as CEO of Inova after 35 years

By Maria Castellucci  |  September 15, 2017

Singleton oversaw the growth of the Falls Church, Va.-based system from $500 million to $3.3 billion in revenue. Recently, he was involved in efforts to bolster Inova's position as a national leader in precision medicine and cancer research.

New cancer center at Henry Ford to break ground

New cancer center at Henry Ford to break ground

By Associated Press  |  June 06, 2017

Plans are moving forward for a new cancer care facility in Detroit. A groundbreaking event takes place Tuesday for the Brigitte Harris Cancer Pavilion, which will be part of the Henry Ford Cancer Institute.

Soon-Shiong unfazed by critics as he touts new cancer therapy

Soon-Shiong unfazed by critics as he touts new cancer therapy

By Maria Castellucci  |  June 06, 2017

In an interview with Modern Healthcare this week, Soon-Shiong said his company's new cancer therapy gets to the root causes of the disease. He also said that recent reports questioning the success of his company's therapies are based on "ignorance," which he "ignores."

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print